The Diagnostic Value of Serum Oncostatin M and Galactin 3 as Biomarkers in Diagnosis of Ulcerative Colitis Disease

Inflammatory bowel diseases (IBD)-Crohn's disease (CD), ulcerative colitis (UC) and inflammatory bowel disease unclassified (IBD-U)-are chronic inflammatory conditions that mainly affect the gastrointestinal tract but might also involve other organs, so they are considered systemic diseases. IBD is mainly diagnosed in young people, and is associated with significant morbidity and disability (Kaplan, 2015). Ulcerative colitis (UC) is an idiopathic, chronic inflammatory illness of the colon that is characterized by continous, diffuse mucosal inflammation (Ordás et al., 2012).

NCT Number	NCT06959654
Lead Sponsor	Sohag University
Conditions	Ulcerative Colitis Disease Patients and Normal Patients
Enrollment	90 participants
Start Date	2025-05-15
Primary Completion	2026-05 (estimated)
Study Completion	2028-05-15 (estimated)
Updated on ClinicalTrials.gov	2025-05-06